Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 12:14:1340737.
doi: 10.3389/fonc.2024.1340737. eCollection 2024.

Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)

Amine Souadka  1   2   3 , Naoual Bakrin  4   5
Affiliations
Editorial

Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)

Amine Souadka et al. Front Oncol. .
No abstract available

Keywords: HIPEC (heated intraperitoneal chemotherapy); PIPAC; cytoreductive surgery (CRS); molecular status; peritoneal surface malignancies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Navigating the Uncharted Waters of Peritoneal Surface Malignancy Management – Key Unresolved Questions. This figure delineates the principal uncertainties and ongoing debates in the treatment of peritoneal surface malignancies. It encompasses a spectrum of critical aspects, from patient selection to the intricacies of surgical and chemotherapeutic interventions. Each segment reflects a pivotal area of inquiry: Patient Selection: The enigma of creating robust, universally applicable criteria for patient eligibility for advanced treatments. Complete Cytoreductive Surgery: The challenge in defining and achieving complete cytoreduction, and the quest for predictive accuracy in preoperative evaluations. HIPEC: The pursuit of standardizing Hyperthermic Intraperitoneal Chemotherapy parameters to balance efficacy and safety. PIPAC: The exploration of long-term efficacy and safety profiles for Pressurized Intraperitoneal Aerosol Chemotherapy. Drug Regimen: The conundrum of optimizing chemotherapeutic agents and regimens tailored to individual patient and tumor profiles. CAR T-Cells and Checkpoint Inhibitors: The exploration into identifying predictive markers for responsiveness to CAR T cells and checkpoint inhibitors in the treatment of peritoneal surface malignancies. Molecular Status: The challenge of integrating molecular diagnostics into personalized treatment strategies. Indication of Each Procedure: The ongoing debate over the specific indications and comparative effectiveness of various treatment modalities.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)

References

    1. Bhatt A, Glehen O, Zivanovic O, Brennan D, Nadeau C, Van Driel W, et al. . The 2022 PSOGI international consensus on HIPEC regimens for peritoneal Malignancies: epithelial ovarian cancer. Ann Surg Oncol (2023). doi: 10.1245/s10434-023-13932-3 - DOI - PubMed
    1. Souadka A, Essangri H, Majbar MA, Benkabbou A, Boutayeb S, You B, et al. . Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in ovarian cancer: an umbrella review of meta-analyses. Front Oncol (2022) 12:809773. doi: 10.3389/fonc.2022.809773 - DOI - PMC - PubMed
    1. Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, et al. . Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology. J Gynecol Obstet Hum Reprod (2019) 48:369–78. doi: 10.1016/j.jogoh.2019.03.017 - DOI - PubMed
    1. Website . Available at: https://meetings.asco.org/abstracts-presentations/219847?0=n&1=u&2=l&3=l.
    1. Dellinger TH, Han ES, Raoof M, Lee B, Wu X, Cho H, et al. . Hyperthermic intraperitoneal chemotherapy-induced molecular changes in humans validate preclinical data in ovarian cancer. JCO Precis Oncol (2022) 6:e2100239. doi: 10.1200/PO.21.00239 - DOI - PMC - PubMed

Publication types

LinkOut - more resources